The project seeks to develop a sophisticated and highly sensitive detection system to develop diagnostic immunosignaturing technology.
The technology will rapidly detect exposure to infectious disease agents before symptoms occur.
ASU officials they hope to develop a silicon chip-based technology capable of detecting a broad range of infectious organisms.
The contract is worth about $9 million for the first year and about $21 million for the final 36 months.
The co-director of the Center for Innovations in Medicine at ASU’s Biodesign Institute — Steven Albert Johnston — will lead the project.